IFNA1 and systemic lupus erythematosus: Intriguingly, individuals at-risk for developing SLE (ANA + , treatment naïve, <1 clinical criteria) also have a significant skin (28.7-fold increase) but lower blood IFN signature (2.2 fold increase) compared to healthy individuals36.